AI dominated two major conference this week, too. At its Ignite conference, Microsoft was only too happy to ride the AI train, taking Copilots into every nook and cranny of the enterprise. At the SC24 ...
AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by immunology competition and risks.